Work

Abstract P1-08-01: MammaPrint ultra-high risk score is associated with response to neoadjuvant chemotherapy in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs13-p1-08-01

Authors: DM Wolf, A Daemen, C Yau, S Davis, A Boudreau, L Swigart, I-SPY 1 Trial Investigators, L Esserman, L van 't Veer

Institutions: University of California, San Francisco, Genentech

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2068429312

Cites:

Cited by: 6

Related to: 10